Systemic and local inflammatory responses to A2P-embedded PLCL biomaterials : a comparative study in a rat model
Year: 2025
Type: dissertation
Abstract: Pelvic organ prolapse (POP) is a common gynecological condition caused by weakened pelvic floor support, leading to descent of pelvic organs such as the bladder, rectum, and uterus. It primarily affects postmenopausal women, with prevalence estimates reaching up to 50% among women over 50, significantly impacting their quality of life. Contributing factors include aging, parity, obesity, and heavy physical exertion. In Finland alone, more than 5,000 pelvic floor surgeries were performed in 2023, with the number expected to rise due to an aging population. Native tissue repair remains the first-line surgical approach for POP treatment. In cases of recurrent POP, synthetic polypropylene (PP) vaginal meshes have been employed. However, the use of PP meshes has been linked to a range of complications, including pain, vaginal wall erosion, infections, and scarring. In response, the U.S. Food and Drug Administration (FDA) reclassified transvaginal surgical meshes as high-risk devices, leading to their withdrawal from POP treatments. This highlights the pressing need for novel, biocompatible biomaterials for safer and more effective POP management. Tissue engineering approaches utilizing biodegradable polymers represent a promising alternative to conventional treatments. Poly(L-lactide-co-ε-caprolactone) (PLCL) is a synthetic, biodegradable polymer that has demonstrated considerable potential in soft tissue engineering applications due to its elasticity, biocompatibility, and ability to support cell attachment and proliferation. The incorporation of bioactive agents such as ascorbic acid (AA) may further enhance the biological functionality of biomaterials by promoting collagen synthesis, reducing oxidative stress, and modulating inflammation. AA has been reported to downregulate proinflammatory cytokines, promote macrophage polarization toward the reparative M2 phenotype, and enhance extracellular matrix (ECM) deposition and angiogenesis, thereby supporting tissue regeneration. This thesis evaluated the biocompatibility and inflammatory response of novel PLCL-based membranes in a rat model by comparing materials containing L-ascorbic acid 2-phosphate (A2P) (A4, A8) with those lacking A2P (PLCL, PP). Systemic inflammation was assessed through the analysis of blood leukocyte distribution and serum cytokine concentrations, while local tissue responses were evaluated using hematoxylin-eosin (HE) and Masson’s trichrome staining. The objective was to determine whether A2P incorporation reduces the overall inflammatory response compared to plain PLCL membranes. The results demonstrated that PLCL elicited a more subdued inflammatory response compared to PP, characterized by lower acute-phase cytokine levels and reduced local inflammation at one month. Additionally, PLCL promoted a shift toward an anti-inflammatory immune response, marked by elevated levels of IL-4 and IL-10. Both A4 and A8 exhibited inflammatory profiles similar to PLCL, characterized by transient systemic and local acute inflammation, while achieving lower local inflammation compared to PP at one month. Although A2P-embedded membranes did not demonstrate a significant anti-inflammatory advantage over PLCL, A8 was associated with a slightly reduced acute-phase cytokine response compared to A4. These findings support the hypothesis that A2P-containing materials do not increase overall inflammation compared to PLCL and PP, indicating their potential suitability for POP applications.
Author: Harju, Päivi Karoliina
Institution: Tampere University
Language: English
Subfield: Urology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: Helsingin Yliopisto
OpenAlex ID: W7132988959
